AZD7442
AZD7442 is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics
AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants
AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19
Clinical Trials (9)
AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics
AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants
AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19
Trial of Treatments for COVID-19 in Hospitalized Adults
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults
ACTIV-3: Therapeutics for Inpatients With COVID-19
Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9